IgA Nephropathy (IgAN) Epidemiology Forecast Reveals Significant Growth by 2032
November 21, 2023 04:58 ET
|
Research and Markets
Dublin, Nov. 21, 2023 (GLOBE NEWSWIRE) -- The "IgA Nephropathy (IgAN) - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. IgA Nephropathy (IgAN) is a...
Idiopathic Membranous Nephropathy (IMN): 7MM Epidemiology Study 2023-2032 - The US Accounted for the Highest Proportion (~41%) of Prevalent Cases in 2022
July 21, 2023 04:28 ET
|
Research and Markets
Dublin, July 21, 2023 (GLOBE NEWSWIRE) -- The "Idiopathic Membranous Nephropathy - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report delivers an...
IgA Nephropathy (IgAN) Market and Competition Landscape 2021-2030
November 25, 2021 04:58 ET
|
Research and Markets
Dublin, Nov. 25, 2021 (GLOBE NEWSWIRE) -- The "IgA Nephropathy (IgAN) - Market Insights, Epidemiology, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. This...
Global IgAN Epidemiology Overview and Outlook: United States has Largest Disease Prevalence
October 28, 2021 04:18 ET
|
Research and Markets
Dublin, Oct. 28, 2021 (GLOBE NEWSWIRE) -- The "IgA Nephropathy (IgAN) - Epidemiology Forecast to 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. This 'IgA Nephropathy...
Global Diabetic Nephropathy Epidemiology and Patient Flow Analysis to 2035
May 18, 2021 06:03 ET
|
Research and Markets
Dublin, May 18, 2021 (GLOBE NEWSWIRE) -- The "Global Diabetic Nephropathy Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering. Global Diabetic...